Palantir Technologies Stock Extends An 8-Day Losing Streak To A 22% Loss
Palantir Technologies (PLTR) stock is on an 8-day losing streak, down 22.1% since the run began. That erased about $105.5 billion from the company’s market value, which now stands at about $372.9 billion. The stock closed at $154.99 on Thursday, November 5, 25.9% below its 52-week high of $209.05 and 44.5% above its low of $107.27.
PLTR Versus The S&P 500
Returns for PLTR and the S&P 500 over the streak and the periods around it, all ending Thursday, November 5 and including dividends:
| Return Period | PLTR | S&P 500 |
|---|---|---|
| 1 Day | -9.7% | -4.4% |
| 8 Days (Current Streak) | -22.1% | -4.2% |
| 1 Month (21 Trading Days) | -20.2% | -5.7% |
| 3 Months (63 Trading Days) | -9.9% | -5.0% |
| Year To Date | -12.8% | 8.4% |
| 1 Year (252 Trading Days) | -18.7% | 9.9% |
A Stock-Specific Slide, Or A Market Move?
The market explains little of this: the S&P 500 lost 4.2% over the same 8 sessions, including dividends, against Palantir Technologies’ -22.1%. No other S&P 500 stock is currently on a losing streak of 8 days or longer. Over the past three months the stock is down 9.9%, a window that includes the streak; over the other 55 sessions of that window it was up 15.6%.
Is The Business As Weak As The Stock?
On the fundamentals, revenue grew 87.1% over the last twelve months, against a median of 17.9% for S&P 500 Information Technology stocks; its operating margin is 45.6%, versus a median of 21.5%; and the stock trades at 101.6 times trailing earnings against a median of 27.4. The read is mixed: revenue growth above the median and margins above the median on one side, a multiple well above the median on the other.
A slide like this raises an obvious follow-up: which marked-down stocks are actually worth buying? Our Buy the Dip screen runs that test every day, flagging beaten-down names whose fundamentals still hold up.
Prefer the theme to the single name? A software ETF like IGV holds the whole group, not just this stock. It is still a concentrated bet on one theme, which is the gap the portfolio below is built to close.
Weakness In One Name Should Be Noise, Not News
For a diversified holder, a streak like this is a data point. For a concentrated one, it is a hole in the plan. The difference is never the stock; it is the portfolio built around it.
Building that portfolio is what the Trefis High Quality (HQ) Portfolio does: roughly 30 businesses with the cash generation and balance-sheet strength to absorb a bad month, selected and rebalanced by rules. It has a track record of outpacing a benchmark that combines the S&P 500, the S&P MidCap 400, and the Russell 2000. Make the next streak, in either direction, someone else’s drama.